Peptides Codex
Home
Neuropeptide

Neuromedin U

Neuromedin U (NmU) is a neuropeptide found in brain and gut, first isolated in 1985 for its uterus-contracting activity. Acting through the NMUR1 and NMUR2 receptors, it suppresses appetite and influences energy balance, making it a target in metabolism research. This page is educational and describes an endogenous peptide, not a product.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
25 aa
Class
Neuropeptide
Function
Signals through NMUR1/NMUR2 receptors in smooth-muscle contraction, appetite suppression and energy balance
Context
Endogenous neuropeptide and target in metabolism and appetite research; not a Health Canada-authorized product

An anorexigenic neuropeptide whose loss produces obesity in mice — a magnet for appetite research.

Also known as: NmU · NMU · NmU-25

Part of the Neuropeptides & signaling cluster

Overview

Neuromedin U (NmU) is a neuropeptide found in brain and gut, first isolated in 1985 for its uterus-contracting activity. Acting through the NMUR1 and NMUR2 receptors, it suppresses appetite and influences energy balance, making it a target in metabolism research. This page is educational and describes an endogenous peptide, not a product.

Source & context

Biological / chemical source: Human brain and gut (endogenous; human form is the 25-residue NmU-25)

Primary research or clinical context: Endogenous neuropeptide and target in metabolism and appetite research; not a Health Canada-authorized product

Structure and receptors

The human peptide is NmU-25, a 25-residue amidated neuropeptide, with shorter active forms found across species. It signals through two G-protein-coupled receptors, NMUR1 (more peripheral) and NMUR2 (more central), a receptor split that helps explain its wide range of actions from smooth-muscle contraction to central appetite control.

Why metabolism researchers care

Within the hypothalamus neuromedin U acts as an anorexigenic signal, suppressing appetite and promoting energy expenditure. Deleting the NMU gene in mice produces an obese, hyperphagic phenotype, while overexpression reduces fat storage — findings that make the NmU system a focus of obesity and metabolism research. This page is educational and makes no treatment claim.

FAQ about Neuromedin U

What is Neuromedin U?+

Neuromedin U (NmU) is a neuropeptide found in brain and gut, first isolated in 1985 for its uterus-contracting activity. Acting through the NMUR1 and NMUR2 receptors, it suppresses appetite and influences energy balance, making it a target in metabolism research. This page is educational and describes an endogenous peptide, not a product.

Is Neuromedin U an approved medicine?+

Neuromedin U is discussed here as a research / educational topic. Endogenous neuropeptide and target in metabolism and appetite research; not a Health Canada-authorized product. This is not medical advice.

What is the typical length of Neuromedin U?+

Neuromedin U is commonly described as approximately 25 amino acids (Neuropeptide).

Related peptides

References & further reading

  1. 1.Wikipedia — Neuromedin U
  2. 2.PubMed — Neuromedin U: a multifunctional neuropeptide with pleiotropic roles (25605682)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Neuromedin U educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.